CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - COM (CRL)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
50.7 M
Holdings value Q1 2024
$13.7 B
Value change Q1 2024
-$714 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
645
Number of buys Q1 2024
323
Number of sells Q1 2024
-267
Average buys Q1 2024 %
+0.006%
Average sells Q1 2024 %
-0.004%
CUSIP
159864107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 50.7 M $13.7 B -$714 K $270.95 645
2023 Q4 51.3 M $12.1 B +$156 M $236.40 611
2023 Q3 50.3 M $9.85 B +$147 M $195.98 603
2023 Q2 50.4 M $10.6 B -$29.7 M $210.25 596
2023 Q1 50.2 M $10.1 B +$259 M $201.82 602
2022 Q4 49.3 M $10.7 B -$104 M $217.90 606
2022 Q3 44.6 M $8.77 B +$296 M $196.80 554
2022 Q2 48.1 M $10.3 B +$408 M $213.97 601
2022 Q1 47.4 M $13.5 B +$106 M $283.97 624
2021 Q4 46.5 M $17.5 B +$196 M $376.78 689
2021 Q3 46.7 M $19.3 B -$271 M $412.67 664
2021 Q2 46.6 M $17.2 B +$133 M $369.92 622
2021 Q1 46.7 M $13.5 B +$147 M $289.83 550
2020 Q4 46.8 M $11.7 B +$73.1 M $249.86 529
2020 Q3 46.1 M $10.4 B +$23.1 M $226.45 480
2020 Q2 39.2 M $6.84 B -$106 M $174.35 448
2020 Q1 46.1 M $5.82 B -$75.1 M $126.21 397
2019 Q4 46.9 M $7.16 B +$24.3 M $152.76 398
2019 Q3 46.4 M $6.14 B +$103 M $132.37 389
2019 Q2 46 M $6.53 B +$153 M $141.90 396
2019 Q1 45.9 M $6.67 B +$95.9 M $145.25 401
2018 Q4 45.2 M $5.12 B -$151 M $113.18 399
2018 Q3 46.2 M $6.22 B +$101 M $134.54 364
2018 Q2 46.3 M $5.19 B -$31.3 M $112.26 341
2018 Q1 47.1 M $5.02 B +$1.9 M $106.74 327
2017 Q4 47.2 M $5.16 B +$108 M $109.45 335
2017 Q3 45.9 M $4.96 B -$9.17 M $108.02 331
2017 Q2 45.8 M $4.63 B -$88.2 M $101.15 295
2017 Q1 46.7 M $4.2 B +$352 M $89.95 294
2016 Q4 45.8 M $3.49 B -$19.9 M $76.19 291
2016 Q3 45.7 M $3.8 B +$8.78 M $83.34 279
2016 Q2 45.9 M $3.79 B -$25.6 M $82.44 276
2016 Q1 46.8 M $3.56 B +$139 M $75.94 257
2015 Q4 44.9 M $3.61 B -$42.2 M $80.39 259
2015 Q3 46 M $2.92 B -$39.1 M $63.52 251
2015 Q2 46.3 M $3.25 B -$16.4 M $70.34 259
2015 Q1 46.7 M $3.7 B +$55.8 M $79.29 256
2014 Q4 46.3 M $2.95 B +$20.4 M $63.64 251
2014 Q3 46.7 M $2.79 B -$86 M $59.74 254
2014 Q2 47.4 M $2.54 B -$9.68 M $53.52 258
2014 Q1 47.6 M $2.87 B +$86.3 M $60.34 256